Nymox Pharmaceutical
NYMX
#10758
Rank
C$26.17 M
Marketcap
Country
C$0.29
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.93 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.36 Million, an increase over its 2021 earnings that were of -C$17.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.93 Million-68.79%
2022 -C$9.36 Million-47.71%
2021 -C$17.9 Million6.61%
2020 -C$16.79 Million-10.91%
2019 -C$18.85 Million24.24%
2018 -C$15.17 Million-20.03%
2017 -C$18.97 Million2.71%
2016 -C$18.47 Million-63.86%
2015 -C$51.1 Million674.44%
2014 -C$6.6 Million-6.11%
2013 -C$7.03 Million-35.66%
2012 -C$10.93 Million-20.76%
2011 -C$13.79 Million38.33%
2010 -C$9.97 Million35.59%
2009 -C$7.35 Million11.8%
2008 -C$6.58 Million-12.94%
2007 -C$7.56 Million8.85%
2006 -C$6.94 Million36.5%
2005 -C$5.09 Million-4.4%
2004 -C$5.32 Million-14.58%
2003 -C$6.23 Million
2001 -C$4.57 Million-20.54%
2000 -C$5.75 Million21.72%
1999 -C$4.73 Million-25.56%
1998 -C$6.35 Million101.3%
1997 -C$3.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.84 B-866,411.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.99 B-322,543.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.35 B-334,112.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.85 B-1,609,040.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$2.13 B-69,142.11%๐Ÿ‡บ๐Ÿ‡ธ USA